Thrombotic thrombocytopenic purpura associated with histamine H2-receptor antagonist therapy

Western Journal of Medicine

Volumn 164, Issue 5, 1996, Pages 446-448

  Kallal, Susan M ^a   Lee, Makau ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; CORTICOSTEROID; FAMOTIDINE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; MUSCLE WEAKNESS; PEPTIC ULCER; SLURRED SPEECH; THROMBOTIC THROMBOCYTOPENIC PURPURA; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PLASMAPHERESIS; REVIEW;

ADRENAL CORTEX HORMONES; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; FAMOTIDINE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PLASMAPHERESIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 0029666299     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Amorosi EL, Ultmann JE: Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine 1966; 45:139-155
2. Bithell TC: Thrombotic thrombocylopenic purpura and other forms of non-immunologic platelet destruction, In Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN (Eds): Clinical Hematology, 9th edition. Philadelphia, Pa, Lea & Febiger, 1993, pp 1356-1361
3. Petitt RM: Thrombotic thrombocytopenic purpura: A thirty year review. Semin Thromb Hemost 1980; 6:350-355
4. Ridolfi RL, Bell WR: Thrombotic thrombocytopenic purpura: Report of 25 cases and review of the literature. Medicine 1981; 60:413-428
5. Thompson CE, Damon LE, Ries CA, Linker CA: Thrombotic microangiopathies in the 1980s: Clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80:1890-1895
6. Schmidt JL: Thrombotic thrombocytopenic purpura: Successful treatment unlocks etiologic secrets. Mayo Clin Proc 1989; 64:956-961
7. Ellingson TL, Wilske K, Aboulafia DM: Thrombotic thrombocytopenic purpura in a patient with polymyositis: Therapeutic importance of early recognition and discussion of pathogenic mechanisms. Am J Med Sci 1992; 303:407-410
8. Ruggenenti P, Remuzzi G: Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 1990; 4:219-241
9. Noda M, Kitagawa M, Tomoda F, Iida H: Thrombotic thrombocytopenic purpura as a complicating factor in a case of polymyositis and Sjögren's syndrome. Am J Clin Pathol 1990; 94:217-221
10. Kwaan HC: Miscellaneous secondary thrombotic microangiopathy. Semin Hematol 1987; 24:141-147
11. Mars DR, Knochel JP, Cotton JR, Fuller TJ: Thrombotic thrombocytopenia purpura after a dogbite. South Med J 1980; 73:676-678
12. Stonesifer LD, Bone RC, Hiller FC: Thrombotic thrombocytopenic purpura in carbon monoxide poisoning - Report of a case. Arch Intern Med 1980; 140:104-105
13. Parker JC, Barrett DA: Microangiopathic hemolysis and thrombocytopenia related to penicillin drugs. Arch Intern Med 1971; 127:474-477
14. Fahal IH, Williams PS, Clark RE, Bell GM: Thrombotic thrombocytopenic purpura due to rifampicin. BMJ 1992; 304:882
15. George JN, El-Harake M: Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms, In Beutler E, Lichtman MA, Coller BS, Kipps TJ (Eds): Hematology, 5th edition. New York, NY, McGraw-Hill, 1995, pp 1290-1303
16. Ahmed F, Sumalnop V, Spain D, Tobin MS: Thrombohemolytic thrombocytopenic purpura during penicillamine therapy. Arch Intern Med 1978; 138: 1292-1293
17. Page Y, Tardy B, Zeni F, Comtet C, Terrana R, Bertrand JC: Thrombotic thrombocytopenic purpura related to ticlopidine. Lancet 1991; 337:774-776
18. Perotti C, Torretta L, Costamagna L, Salvaneschi L: Thrombotic thrombocytopenic purpura after defibrotide therapy. Haematologica 1994; 79:569
19. Drugdex: Drug evaluations, In Gelman CR, Ruimack BH (Eds): Drugdex Information System [online database]. Denver, Colo, Micromedex, Inc, 1995
20. Aymard JP, Aymard B, Netter P, Bannwarth B, Trechot P, Streiff F: Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol 1988; 3:430-448
21. List AF, Beaird DH, Kummet T: Ranitidine-induced granulocytopenia: Recurrence with cimetidine administration. Ann Intern Med 1988; 108:566-567
22. Shumak KH, Rock GA, Nair RC, the Canadian Apheresis Group: Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med 1995; 122:569-572
23. Bell WR, Braine HG, Ness PM, Kickler TS: Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. N Engl J Med 1991; 325:398-403
24. Nalbandian RM, Henry RL: A proposed comprehensive pathophysiology of thrombotic thrombocytopenia purpura with implicit novel tests and therapies. Semin Thromb Hemost 1980; 6:356-390
25. Harkness DR, Byrnes JJ, Lian ECY, Williams WD, Hensley GT: Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981; 246:1931-1933